PrimeX News

Broker News

CBA Slump and Weak Breadth Pressure ASX 200 Index as Miners Hold Firm
Thu, 14 May 2026 00:00:12 GMT
S&P 500 Forecast: AI Stocks Drive Rally as Hot PPI and Weak Breadth Test Bulls
Wed, 13 May 2026 21:00:01 GMT
Gold (XAU/USD) Price Forecast: 100-Day Average Defines Next Move
Wed, 13 May 2026 20:44:50 GMT
Rigetti Computing (RGTI) Price Forecast: Quantum Stock Near Critical Breakout Level
Wed, 13 May 2026 20:37:48 GMT
Natural Gas Price Forecast: Breakout Build Toward Higher Targets
Wed, 13 May 2026 20:28:44 GMT
Gold News: Gold Price Future Weakens After PPI Shock and Rising Treasury Yields
Wed, 13 May 2026 19:54:08 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
Silver (XAG) Forecast: Weak Below 50-Day MA, Silver Analysis Signals More Downside
Tue, 21 Apr 2026 17:29:23 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT

XENE

Xenon Pharmaceuticals Inc

55.88

USD

Xenon Pharmaceuticals Inc Profile

About

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.

Info & Links

CEO

Ian Mortimer

Headquarters

200-3650 GILMORE WAY
BURNABY, A1 V5G 4W8, CANADA

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

370

Xenon Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

5.40B

Enterprise Value

5.20B

Enterprise Value/EBITDA(ttm)

-14.04

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

7.78

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-216.82%

Return on Equity(ttm)

-55.81%

Return on Invested Capital(ttm)

-56.94%

Return on Assets(ttm)

-52.04%

Income Statement

Revenue(ttm)

7.50M

Revenue Per Share(ttm)

0.09

Gross Profit(ttm)

7.50M

EBITDA(ttm)³

-370.53M

Net Income Available to Common(ttm)

-345.91M

Diluted EPS(ttm)

-4.36

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

55.87%

S&P 500 52-Week Change

26.46%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

83.19M

Dividend Yield

0.00%

Float⁴

79.80M

% Held by Insiders

4.07%

% Held by Institutions

95.45%

Balance Sheet

Total Cash(mrq)

548.89M

Total Cash Per Share(mrq)

6.60

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.42%

Quick Ratio(mrq)

13.42%

Book Value Per Share(mrq)

7.27

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.52

Free Cash Flow(ytd)

-279.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.